Bevacizumab: all 1,786 studies that test it
Page 17 of 18. Open to participants first (285), then studies with results posted, then the rest; newest registration first within each.
- Oxaliplatin and Paclitaxel Plus Bevacizumab in Advanced Peritoneal CarcinomatosisCompletedNCT00491855Phase 1
- A Phase II Study of Bevacizumab, Irinotecan and Capecitabine in Patients With Previously Untreated Metastatic Colorectal CancerCompletedNCT00483834Phase 2
- Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Newly Diagnosed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity CancerCompletedNCT00483782Phase 3
- Bevacizumab in Treating Patients With Relapsed or Refractory Multiple MyelomaCompletedNCT00482495Phase 2
- Bevacizumab and Abraxane as Second-line Therapy in Triple Negative Metastatic Breast CancerCompletedNCT00472693Phase 2
- Enzastaurin, Carboplatin, and Gemcitabine With or Without Bevacizumab in Treating Patients With Recurrent, Stage IIIB, or Stage IV Non-Small Cell Lung CancerWithdrawnNCT00469976Phase 2
- Treatment Study Using Bevacizumab for Patients With Adrenocortical CarcinomaWithdrawnNCT00469469Phase 2
- Sirolimus and Bevacizumab in Treating Patients With Liver Cancer That Cannot Be Removed by SurgeryCompletedNCT00467194Phase 1
- Phase Ⅱ Clinical Study of R435 (Bevacizumab) in Combination With Paclitaxel in Patients With Inoperable Metastatic Breast CancerCompletedNCT00467012Phase 2
- TAC-PF, Avastin® in Combination With Photodynamic Therapy to Treat Age Related Macular DegenerationTerminatedNCT00464347Phase 2
- Bevacizumab and Irinotecan for Patients With Primary Brain Tumors and Progression After Standard TherapyCompletedNCT00463203Phase 2
- Cetuximab, Bevacizumab and Irinotecan for Patients With Malignant GlioblastomasCompletedNCT00463073Phase 2
- Gemcitabine, Bevacizumab, and Abdominal Radiation Therapy in Treating Patients With Localized Pancreatic CancerCompletedNCT00460174Phase 2
- Bevacizumab and Cediranib Maleate in Treating Patients With Metastatic or Unresectable Solid Tumor, Lymphoma, Intracranial Glioblastoma, Gliosarcoma or Anaplastic AstrocytomaCompletedNCT00458731Phase 1
- Cisplatin/Paclitaxel/Gemcitabine +/- Avastin in Patients With Unknown Primary TumorWithdrawnNCT00458315Phase 2
- Iodine I 131 Monoclonal Antibody 3F8 and Bevacizumab in Treating Patients With Relapsed or Refractory NeuroblastomaCompletedNCT00450827Phase 1
- Chemotherapy With or Without Bevacizumab or Lapatinib to Treat Operable Oesophagogastric CancerStatus unknownNCT00450203Phase 2/3
- Combination Therapy for Neovascular Age Related Macular DegenerationWithdrawnNCT00447031Not applicable
- Bevacizumab and Doxorubicin Hydrochloride Liposome in Treating Women With Locally Recurrent or Metastatic Breast CancerCompletedNCT00445406Phase 2
- Pre- and Postoperative Chemotherapy Including Bevacizumab in Potentially Curable Metastatic Colorectal CancerCompletedNCT00444041Phase 1/2
- Safety Study of Specific Tumor Target Drug Plus Immune System Therapy in Patients With Kidney CancerTerminatedNCT00440973Phase 2
- Cetuximab, Leucovorin, Oxaliplatin, and Fluorouracil With or Without Bevacizumab in Treating Patients With Resectable Liver Metastases From Colorectal CancerStatus unknownNCT00438737Phase 2
- Bevacizumab, Doxorubicin, and Cyclophosphamide Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients Who Have Undergone Surgery for Early-Stage Breast CancerStatus unknownNCT00436709Not applicable
- 5-FU, Folinic Acid and Irinotecan (FOLFIRI) Plus Cetuximab Versus FOLFIRI Plus Bevacizumab in First Line Treatment Colorectal Cancer (CRC)Status unknownNCT00433927Phase 3
- Bevacizumab and Bortezomib in Patients With Advanced MalignancyCompletedNCT00428545Phase 1
- Combination Bevacizumab and Verteporfin (Two Different Sequences of Treatment)in Neovascular AMDCompletedNCT00426998Phase 2
- Proton Therapy and Bevacizumab for Primary Liver TumorsTerminatedNCT00426829Phase 1
- Imatinib Mesylate and Bevacizumab After First-Line Chemotherapy and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00425646Phase 2
- Intravitreal Bevacizumab for Proliferative Diabetic RetinopathyCompletedNCT00423059Not applicable
- A Phase I Study of Bevacizumab and Sunitinib in Metastatic Renal Cell Carcinoma PatientsCompletedNCT00421512Phase 1
- Intravitreal Bevacizumab for the Treatment of Central Serous ChorioretinopathyWithdrawnNCT00418431Phase 2/3
- Multifocal Electrophysiologic Findings After Intravitreal Bevacizumab(Avastin)TreatmentTerminatedNCT00417833Phase 2/3
- Use of Intravitreal Bevacizumab in Patients With Diffuse Diabetic Macular EdemaWithdrawnNCT00417716Phase 3
- Bevacizumab in Treating Patients With Advanced Solid TumorsCompletedNCT00416637Phase 1
- Phase I-II for Patients With Recurrent or Refractory Non-small Cell Lung Cancer (NSCLC)WithdrawnNCT00411593Phase 1/2
- Gemcitabine and Bevacizumab in Treating Patients With Pancreatic Cancer That Has Been Completely Removed By SurgeryTerminatedNCT00410774Phase 1/2
- Oxaliplatin, Capecitabine, and Bevacizumab Followed By Surgery and/or Radiofrequency Ablation in Patients With Colorectal CancerWithdrawnNCT00408772Phase 2
- Bevicizumab (Avastin) Infusion for Choroidal Neovascularization (CNV) Not Associated With Age-Related Macular Degeneration (AMD)CompletedNCT00407719Phase 1
- Phase II Study of Bevacizumab, Pemetrexed and Carboplatin as First-Line Therapy in Malignant Pleural MesotheliomaCompletedNCT00407459Phase 2
- Intravitreal Bevacizumab for Inflammatory Neovascular MembranesWithdrawnNCT00407121Phase 3
- Efficacy of Retreatments With Intravitreal BevacizumabTerminatedNCT00406744Phase 3
- Effect of Avastin in Juxtafoveal TelangiectasiasWithdrawnNCT00406380Phase 3
- Intravitreal Bevacizumab (Avastin) for Pseudophakic Macular Edema (PME)WithdrawnNCT00406172Phase 3
- Phase I of Biologics and Chemoradiation Therapy for Advanced Head and Neck CancerCompletedNCT00405405Phase 1
- ABI-007 and Bevacizumab in Treating Women With Recurrent or Metastatic Breast CancerStatus unknownNCT00404404Phase 2
- Intravitreal Bevacizumab for Retinal DisordersStatus unknownNCT00403026Not applicable
- Safety Study of Increasing Doses of Combretastatin in Combination With Bevacizumab (Avastin) in Patients With Advanced Solid TumorsCompletedNCT00395434Phase 1
- Adjuvant Xeloda Plus Eloxatin +/- Avastin After Radical Resection of Liver Metastasis of Colorectal CancerTerminatedNCT00394992Phase 3
- A Pilot Study of VEGF Inhibition in Patients With Lymphedema Following Breast Cancer TreatmentCompletedNCT00393497Phase 1
- Imatinib, Bevacizumab, and Cyclophosphamide in Patients With Refractory Metastatic Solid TumorsCompletedNCT00390156Phase 1
- The Avastin vs Visudyne for Neovascular AMD StudyWithdrawnNCT00390026Phase 3
- A New Agent GM-CT-01 in Combination With 5-FU, Avastin and Leucovorin in Subjects With Colorectal CancerWithdrawnNCT00388700Phase 2
- Bevacizumab, Cisplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung CancerCompletedNCT00387699Phase 2
- Radiation Therapy, Bevacizumab, Paclitaxel, and Carboplatin in Treating Patients With Unresectable Stage IIIB or Stage IV Non-Small Cell Lung Cancer at High Risk for Hemoptysis Caused by BevacizumabCompletedNCT00387374Phase 2
- Chemoradiation for Locally Advanced and Low Rectal Cancers: Avastin-Capecitabine-Oxaliplatin-Radiation REctal Cancer TrialCompletedNCT00386828Phase 2
- ChronoFOLFOX Plus Avastin for Patients With Metastatic Colorectal CancerTerminatedNCT00385021Phase 2
- Intravitreal Bevacizumab for Neovascular GlaucomaCompletedNCT00384631Not applicable
- Intravitreal Bevacizumab for Polypoidal Choroidal VasculopathyStatus unknownNCT00383812Not applicable
- Phase II Study of Bevacizumab, Capecitabine and Oxaliplatin in Colon CancerCompletedNCT00378066Phase 2
- Combination Therapy for Age-Related Macular Degeneration.CompletedNCT00376701Phase 2
- Intravitreal Bevasizumab VS Sham Treatment in Acute BRVO: A Randomized Clinical TrialCompletedNCT00370851Phase 3
- Effect of Intravitreal Bevacizumab on Non -Age-Related Macular Degeneration (AMD) Related Choroidal Neovascularization (CNV)CompletedNCT00370786Phase 3
- Intravitreal Bevacizumab for Management of Active Progressive Proliferative Diabetic Retinopathy (PDR)Status unknownNCT00370721Phase 3
- Effect of Intravitreal Bevacizumab on Clinically Significant Macular EdemaStatus unknownNCT00370669Phase 3
- Intravitreal Avastin Versus Intravitreal Avastin and Triamcinolone in Central Retinal Vein Occlusion(CRVO)Status unknownNCT00370630Phase 2
- Combined PDT and Intravitreal Bevacizumab vs Combination of PDT, Intravitreal Bevacizumab and Triamcinolone for Neovascular AMDStatus unknownNCT00370539Phase 3
- Bevacizumab Versus Combined Bevacizumab and Triamcinolone for Refractory Diabetic Macular Edema; a Randomized Clinical TrialStatus unknownNCT00370422Phase 3
- Intravitreal Bevacizumab vs. Bevacizumab Combined With Triamcinolone for Neovascular AMDStatus unknownNCT00370370Phase 3
- A Study to Test the Safety and Efficacy of Erlotinib Plus Bevacizumab to Treat Advanced Thymoma and Thymic CancerCompletedNCT00369889Phase 2
- Bevacizumab, Paclitaxel, Carboplatin, and Radiation Therapy to the Chest in Treating Patients With Locally Advanced Non-Small Cell Lung CancerTerminatedNCT00369551Phase 1
- Bevacizumab and Sunitinib in Treating Patients With Solid TumorsCompletedNCT00357318Phase 1
- Bevacizumab and Erlotinib Followed by Cisplatin or Carboplatin and Gemcitabine in Treating Patients With Newly Diagnosed or Recurrent Stage IIIB or Stage IV NSCLCCompletedNCT00354549Phase 2
- Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) With Bevacizumab and Irinotecan for Malignant GliomaCompletedNCT00352521Phase 2
- Bevacizumab With Hormonal and Radiotherapy for High-Risk Prostate CancerCompletedNCT00349557Phase 2
- Bevacizumab, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate CancerStatus unknownNCT00348998Phase 2
- Intravitreal Bevacizumab vs Photocoagulation for Proliferative Diabetic RetinopathyWithdrawnNCT00347698Phase 2/3
- Clinical Study of Capecitabine, Oxaliplatin and Bevacizumab in Colorectal CancerCompletedNCT00345761Phase 1/2
- 1stline Study Capecitabine Administered on Continuous Way Plus Oxaliplatin&Bevacizumab Every 2weeks in Metastatic CCR.CompletedNCT00345696Phase 2
- Off-Label AVASTIN (BEVACIZUMAB) For Serosanguinous MaculopathyStatus unknownNCT00344617Phase 3
- Preop Chemoradiation Resectable PancreasCompletedNCT00336648Phase 2
- Radiation Therapy, Chemotherapy, and Bevacizumab in Treating Patients With Recurrent, Unresectable or Stage III or Stage IV Non-Small Cell Lung CancerTerminatedNCT00334763Phase 2
- Elaboration of a Model for Predicting Efficacy of Monoclonal Antibodies (Cetuximab and Bevacizumab) in Patients With Colorectal Cancer and Liver MetastasesTerminatedNCT00327093Phase 4
- FOLFIRI + Bevacizumab With or Without Dalteparin in First Line Treatment of Advanced Colorectal CancerTerminatedNCT00323011Phase 2
- Safety Study of Bevacizumab to Treat Women With a History of Breast Cancer and Suffering From Upper Extremity LymphedemaStatus unknownNCT00318513Phase 1
- A Study of Paclitaxel Plus Bevacizumab in Patients With Chemosensitive Relapsed Small Cell Lung CancerCompletedNCT00317200Phase 2
- Randomized Ph 2 Trial Of Paclitaxel/Carboplatin /Bevacizumab + PF-3512676 And P/C/B Alone In Advanced Nonsquamous NSCLCTerminatedNCT00313768Phase 2
- Vinorelbine and Bevacizumab in Treating Older Patients With Stage III or Stage IV Non-Small Cell Lung CancerCompletedNCT00309998Phase 2
- Bevacizumab, Dacarbazine and Interferon-Alfa to Treat Metastatic MelanomaCompletedNCT00308607Phase 2
- Irinotecan, Carboplatin, Bevacizumab, and Radiation Therapy in the Treatment of Limited Stage Small Cell Lung CancerCompletedNCT00308529Phase 2
- Study of Bevacizumab in Combination With 5-FU, Oxaliplatin and External Beam Radiation Followed by Gemcitabine and Bevacizumab for Locally Advanced Pancreatic CancerTerminatedNCT00307723Phase 1/2
- Bevacizumab and Letrozole in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer That Cannot Be Removed By SurgeryCompletedNCT00305825Phase 2
- Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney CancerStatus unknownNCT00301990Phase 2
- Dose Dense Therapy and Bevacizumab in Solid Tumors and Colorectal CancerTerminatedNCT00296062Phase 1
- Irinotecan, Carboplatin, Bevacizumab in the Treatment of Patients With Extensive Stage Small Cell Lung CancerCompletedNCT00294931Phase 2
- The MAX Study: Mitomycin C, Avastin and Xeloda in Patients With Untreated Metastatic Colorectal CancerCompletedNCT00294359Phase 2/3
- Docetaxel, Carboplatin, and Bevacizumab in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Can Be Removed By SurgeryTerminatedNCT00293332Phase 2
- Transarterial Chemoembolisation Plus Bevacizumab for Treatment of Hepatocellular CarcinomaTerminatedNCT00280007Phase 2
- Bevacizumab, Everolimus, and Erlotinib in Treating Patients With Advanced Solid TumorsCompletedNCT00276575Phase 1
- Phase IB Study of Gemcitabine, Docetaxel and Bevacizumab in Patients With Soft Tissue SarcomaCompletedNCT00276055Phase 1
- Pemetrexed Disodium and Bevacizumab in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerCompletedNCT00268489Phase 2